Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C28H28N4O |
| Molecular Weight | 436.5481 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1NC2=C(C=CC=C2)N1C3CCN(CCC(C#N)(C4=CC=CC=C4)C5=CC=CC=C5)CC3
InChI
InChIKey=PHOZZEGHYJVRDX-UHFFFAOYSA-N
InChI=1S/C28H28N4O/c29-21-28(22-9-3-1-4-10-22,23-11-5-2-6-12-23)17-20-31-18-15-24(16-19-31)32-26-14-8-7-13-25(26)30-27(32)33/h1-14,24H,15-20H2,(H,30,33)
| Molecular Formula | C28H28N4O |
| Molecular Weight | 436.5481 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:17:43 GMT 2023
by
admin
on
Sat Dec 16 10:17:43 GMT 2023
|
| Record UNII |
UMD9OSD01W
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
281-236-3
Created by
admin on Sat Dec 16 10:17:43 GMT 2023 , Edited by admin on Sat Dec 16 10:17:43 GMT 2023
|
PRIMARY | |||
|
UMD9OSD01W
Created by
admin on Sat Dec 16 10:17:43 GMT 2023 , Edited by admin on Sat Dec 16 10:17:43 GMT 2023
|
PRIMARY | |||
|
3086173
Created by
admin on Sat Dec 16 10:17:43 GMT 2023 , Edited by admin on Sat Dec 16 10:17:43 GMT 2023
|
PRIMARY | |||
|
DTXSID70232790
Created by
admin on Sat Dec 16 10:17:43 GMT 2023 , Edited by admin on Sat Dec 16 10:17:43 GMT 2023
|
PRIMARY | |||
|
83898-28-6
Created by
admin on Sat Dec 16 10:17:43 GMT 2023 , Edited by admin on Sat Dec 16 10:17:43 GMT 2023
|
PRIMARY | |||
|
DESPROPIONYLBEZITRAMIDE
Created by
admin on Sat Dec 16 10:17:43 GMT 2023 , Edited by admin on Sat Dec 16 10:17:43 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
METABOLITE ACTIVE -> PRODRUG | |||
|
PRODRUG -> METABOLITE ACTIVE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
From DrugBank on the parent compound: Bezitramide acts in the body to relieve pain with a potency 20 times that of methadone. Its duration of action is relatively long, lasting up to 12 hours post oral administration, after the achievement of steady state. Its onset of action is slow, with a peak in analgesic effect noted between 2.5-3.5 hours after dosing. It is noted to illicit a strong antitussive effect, which could be of benefit to patients with bronchial carcinoma.
|
